Global Next-Generation Sequencing (NGS) Services Market Size By Type (Targeted, RNA-Seq), By Application (Diagnostics, Oncology), By Region, And Segment Forecasts, 2023 to 2032

The Global Next-Generation Sequencing (NGS) Services Market was valued at USD 7.2 billion in 2023 and is projected to reach USD 18.6 billion by 2031, expanding at a CAGR of 12.5% from 2023 to 2031. The market's rapid growth is driven by advancements in genomics, increasing demand for precision medicine, and the declining cost of sequencing technologies. NGS services are revolutionizing fields such as oncology, reproductive health, and rare disease diagnostics by providing high-throughput and cost-effective genomic analysis solutions. As healthcare systems and research institutes increasingly rely on genomics for clinical and diagnostic decision-making, the demand for outsourced NGS services continues to rise globally.

Drivers:

1. Rising Adoption of Precision Medicine:

Personalized medicine requires detailed genetic information to tailor therapies for individual patients. NGS enables high-throughput sequencing, offering comprehensive insights that are essential for personalized treatment strategies in oncology and other chronic diseases.

2. Technological Advancements in Sequencing Platforms:

Innovations such as nanopore sequencing, single-cell sequencing, and long-read technologies are enhancing the scope and utility of NGS. These developments are improving data accuracy, throughput, and turnaround time, boosting the demand for specialized sequencing services.

3. Growing Demand in Clinical Diagnostics:

The increasing use of NGS in diagnostics, including cancer screening, non-invasive prenatal testing (NIPT), and rare disease identification, is significantly fueling market growth. Healthcare providers are increasingly outsourcing NGS to reduce in-house infrastructure costs and access expert analysis.

Restraints:

1. Data Interpretation and Storage Challenges:

The large volumes of data generated by NGS require sophisticated bioinformatics tools and substantial storage infrastructure. These requirements pose challenges for smaller facilities and hinder adoption in some regions.

2. High Cost of Custom NGS Services:

While sequencing costs have dropped, the total cost of outsourced NGS services—including sample preparation, bioinformatics, and result interpretation—can still be prohibitive for smaller research institutions and clinics.

Opportunity:

1. Expansion into Emerging Markets:

With increasing investments in healthcare infrastructure and research across Asia-Pacific, Latin America, and the Middle East, service providers have vast opportunities to expand their geographic footprint and offer tailored NGS services in these regions.

2. Integration of AI in Genomic Analysis:

Artificial Intelligence (AI) is being increasingly integrated into bioinformatics pipelines to accelerate and refine genomic interpretation. This presents a major opportunity to enhance the speed and quality of NGS service offerings.

Market by System Type Insights:

The Whole Genome Sequencing (WGS) segment accounted for the largest market share in 2023, driven by its comprehensive coverage and decreasing costs. However, Targeted Sequencing is expected to register the highest growth rate during the forecast period due to its efficiency and cost-effectiveness for specific clinical applications, such as oncology and infectious disease profiling.

Market by End-use Insights:

By end-use, Academic & Research Institutes dominated the market in 2023, owing to the widespread use of NGS in genetic and biomedical research. The Hospitals & Clinics segment is projected to grow at the fastest pace, driven by the rising adoption of NGS for routine clinical diagnostics, including cancer and rare disease detection.

Market by Regional Insights:

North America led the market in 2023, supported by strong government funding for genomics research, the presence of major market players, and early adoption of advanced technologies. Asia-Pacific is expected to exhibit the highest growth through 2031, fueled by rising healthcare expenditure, expanding genomics research capabilities, and favorable regulatory support in countries like China, Japan, and India.

Competitive Scenario:

Key players in the Global NGS Services Market include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co. Ltd., Eurofins Scientific, Macrogen Inc., PerkinElmer Inc., GENEWIZ (a Brooks Life Sciences Company), QIAGEN N.V., Fulgent Genetics, and MedGenome Inc. These companies are focusing on expanding their service portfolios, forging strategic collaborations, and leveraging AI-enabled platforms to stay competitive.

Scope of Work – Global Next-Generation Sequencing (NGS) Services Market

Report Metric Details

Market Size (2023) USD 7.2 billion

Projected Market Size (2031) USD 18.6 billion

CAGR (2023–2031) 12.5%

Key Segments By System Type (WGS, WES, Targeted, RNA Seq), By End-use (Hospitals & Clinics, Research Institutes, Pharma & Biotech)

Growth Drivers Rise in precision medicine, tech advancements in sequencing, increased use in diagnostics

Opportunities AI in bioinformatics, emerging market expansion

Key Market Developments:

2023: Illumina partnered with a major health system to provide whole-genome sequencing for population health genomics.

2024: Thermo Fisher launched an ultra-fast NGS service platform with integrated AI-powered variant interpretation.

2025: Eurofins Scientific expanded its NGS services in India, focusing on oncology diagnostics for underserved markets.

FAQs:

1) What is the current market size of the Global Next-Generation Sequencing (NGS) Services Market?

The market size in 2023 is valued at USD 7.2 billion.

2) What is the major growth driver of the Global Next-Generation Sequencing (NGS) Services Market?

The rise in demand for precision medicine and clinical diagnostics is the primary growth driver.

3) Which is the largest region during the forecast period in the Global Next-Generation Sequencing (NGS) Services Market?

North America is expected to remain the largest region due to advanced infrastructure and early adoption.

4) Which segment accounted for the largest market share in the Global Next-Generation Sequencing (NGS) Services Market?

Whole Genome Sequencing (WGS) held the largest share in 2023.

5) Who are the key market players in the Global Next-Generation Sequencing (NGS) Services Market?

Key players include Illumina, Thermo Fisher Scientific, BGI Genomics, Eurofins, Macrogen, and QIAGEN.